Towa Pharmaceutical Co., Ltd. (TYO:4553)
3,345.00
-35.00 (-1.04%)
Nov 13, 2026, 3:30 PM JST
Towa Pharmaceutical Market Cap
Towa Pharmaceutical has a market cap or net worth of 164.7 billion as of November 13, 2026. It is the 9,797th most valuable company in the world and the 735th biggest in Japan. Its market cap has increased by 13.84% in one year.
Market Cap
164.70B
Enterprise Value
334.37B
Revenue
285.49B
Global Rank
Country Rank
#735 Japan
PE Ratio
42.20
ChartMarket Cap Chart
Since January 20, 1995, Towa Pharmaceutical's market cap has increased from 104.94B to 164.70B, an increase of 56.95%. That is a compound annual growth rate of 1.43%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 164.70B | -8.09% |
| Dec 30, 2025 | 179.19B | 8.50% |
| Dec 30, 2024 | 165.16B | 42.67% |
| Dec 29, 2023 | 115.76B | 10.36% |
| Dec 30, 2022 | 104.89B | -25.58% |
| Dec 30, 2021 | 140.95B | 49.63% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Tsumura & Co. | 294.01B |
| Nippon Shinyaku | 228.89B |
| Sawai Group Holdings | 188.45B |
| Kissei Pharmaceutical | 162.15B |
| Kaken Pharmaceutical | 144.85B |
| Mochida Pharmaceutical | 117.84B |
| Zeria Pharmaceutical | 92.04B |
| KYORIN Pharmaceutical | 62.04B |